1.Anderson, DW, Ellenberg, JH, Leventhal, CM, Reingold, SC, Rodriguez, M, Silberberg, DH. Revised estimate of the prevalence of multiple sclerosis in the united states. Ann Neurol 1992 Mar;31(3):333–6.
2.Prineas, J. Pathology of multiple sclerosis. in Cook, S, ed. Handbook of Multiple Sclerosis In: New York: Marcel Dekker; 2001. p. 289–324.
3.Frohman, EM, Racke, MK, Raine, CS. Multiple sclerosis – the plaque and its pathogenesis. N Engl J Med 2006 Mar 2;354(9):942–55.
4.Marburg, O. Die sogennate akute multiple sklerose. Jahrb Psychiatrie 1906;27:211–312.
5.Putnam, T. Studies in multiple sclerosis. Arch Neurol Psych 1936;35:1289–308.
6.van Waesberghe, JH, Kamphorst, W, De Groot, CJ, van Walderveen, MA, Castelijns, JA, Ravid, R, et al. Axonal loss in multiple sclerosis lesions: Magnetic resonance imaging insights into substrates of disability. Ann Neurol November 1999;46(5):747–54.
7.De Stefano, N, Narayanan, S, Francis, GS, Arnaoutelis, R, Tartaglia, MC, Antel, JP, et al. Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. Arch Neurol January 2001;58(1):65–70.
8.Compston, A, Coles, A. Multiple sclerosis. Lancet April 6, 2002;359(9313):1221–31.
9.Miller, DH. Biomarkers and surrogate outcomes in neurodegenerative disease: Lessons from multiple sclerosis. NeuroRx April 2004;1(2):284–94.
10.Minneboo, A, Uitdehaag, BM, Jongen, P, Vrenken, H, Knol, D, van Walderveen, MA, et al. Association between MRI parameters and the MS severity scale: A 12 year follow-up study. Multiple Sclerosis May 2009;15(5):632–7.
11.Calabrese, M, Atzori, M, Bernardi, V, Morra, A, Romualdi, C, Rinaldi, L, et al. Cortical atrophy is relevant in multiple sclerosis at clinical onset. J Neurol September 2007;254(9):1212–20.
12.Calabrese, M, Agosta, F, Rinaldi, F, Mattisi, I, Grossi, P, Favaretto, A, et al. Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch Neurol September 2009;66(9):1144–50.
13.Rawes, JA, Calabrese, VP, Khan, OA, DeVries, GH. Antibodies to the axolemma-enriched fraction in the cerebrospinal fluid and serum of patients with multiple sclerosis and other neurological diseases. Multiple Sclerosis December 1997;3(6):363–9.
14.Madigan, MC, Rao, NS, Tenhula, WN, Sadun, AA. Preliminary morphometric study of tumor necrosis factor-alpha (TNF alpha)-induced rabbit optic neuropathy. Neurol Res June 1996;18(3):233–6.
15.Shindler, KS, Ventura, E, Dutt, M, Rostami, A. Inflammatory demyelination induces axonal injury and retinal ganglion cell apoptosis in experimental optic neuritis. Exp Eye Res September 2008;87(3):208–13.
16.Frischer, JM, Bramow, S, Dal-Bianco, A, Lucchinetti, CF, Rauschka, H, Schmidbauer, M, et al. The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain May 2009;132(Pt 5):1175–89.
17.Kappos, L, Moeri, D, Radue, EW, Schoetzau, A, Schweikert, K, Barkhof, F, et al. Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: A meta-analysis. gadolinium MRI meta-analysis group. Lancet March 20, 1999;353(9157):964–9.
18.Fisniku, LK, Brex, PA, Altmann, DR, Miszkiel, KA, Benton, CE, Lanyon, R, et al. Disability and T2 MRI lesions: A 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain March 2008;131(Pt 3):808–17.
19.De Stefano, N, Matthews, PM, Fu, L, Narayanan, S, Stanley, J, Francis, GS, et al. Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. results of a longitudinal magnetic resonance spectroscopy study. Brain August 1998;121 ( Pt 8)(Pt 8):1469–77.
20.Fisher, E, Rudick, RA, Simon, JH, Cutter, G, Baier, M, Lee, JC, et al. Eight-year follow-up study of brain atrophy in patients with MS. Neurology November 12, 2002;59(9):1412–20.
21.Calabrese, M, De Stefano, N, Atzori, M, Bernardi, V, Mattisi, I, Barachino, L, et al. Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis. Arch Neurol October 2007;64(10):1416–22.
22.Inglese, M, Oesingmann, N, Casaccia, P, Fleysher, L. Progressive multiple sclerosis and gray matter pathology: An MRI perspective. Mt Sinai J Med March–April 2011;78(2):258–67.
23.Simon, JH. Brain atrophy in multiple sclerosis: What we know and would like to know. Multiple Sclerosis December 2006;12(6):679–87.
24.Lucchinetti, CF, Popescu, BF, Bunyan, RF, Moll, NM, Roemer, SF, Lassmann, H, et al. Inflammatory cortical demyelination in early multiple sclerosis. N Engl J Med December 8, 2011;365(23):2188–97.
25.Brownell, B, Hughes, JT. The distribution of plaques in the cerebrum in multiple sclerosis. J Neurol Neurosurg Psychiatry November 1962;25:315–20.
26.Lumsden, C. The neuropathology of multiple sclerosis. In: Vinken, PJ, bruyn, GW, eds. Handbook of Clinical Neurology. Amsterdam: Elsevier; 1970. pp. 217–309.
27.Bo, L, Vedeler, CA, Nyland, HI, Trapp, BD, Mork, SJ. Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol July 2003;62(7):723–32.
28.Moll, NM, Rietsch, AM, Ransohoff, AJ, Cossoy, MB, Huang, D, Eichler, FS, et al. Cortical demyelination in PML and MS: Similarities and differences. Neurology January 29, 2008;70(5):336–43.
29.Lovato, L, Willis, SN, Rodig, SJ, Caron, T, Almendinger, SE, Howell OW, et al. Related B cell clones populate the meninges and parenchyma of patients with multiple sclerosis. Brain. February 2011;134(Pt 2):534–41.
30.Oh, J, Zackowski, K, Chen, M, Newsome, S, Saidha, S, Smith, SA, et al. Multiparametric MRI correlates of sensorimotor function in the spinal cord in multiple sclerosis. Multiple Sclerosis. April 2013;19(4):427–35.
31.Filippi, M, Rocca, MA, De Stefano, N, Enzinger, C, Fisher, E, Horsfield, MA, et al. Magnetic resonance techniques in multiple sclerosis: The present and the future. Arch Neurol December 2011;68(12):1514–20.
32.Saidha, S, Syc, SB, Ibrahim, MA, Eckstein, C, Warner, CV, Farrell, SK, et al. Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain February 2011;134(Pt 2):518–33.
33.Saidha, S, Syc, SB, Durbin, MK, Eckstein, C, Oakley, JD, Meyer, SA, et al. Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness. Multiple Sclerosis. August 24, 2011;
34.Syc, SB, Saidha, S, Newsome, SD, Ratchford, JN, Levy, M, Ford, E, et al. Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis. Brain October 17, 2011;
35.Seigo, MA, Sotirchos, ES, Newsome, S, Babiarz, A, Eckstein, C, Ford, E, et al. In vivo assessment of retinal neuronal layers in multiple sclerosis with manual and automated optical coherence tomography segmentation techniques. J Neurol March 15, 2012;
36.Frohman, EM, Fujimoto, JG, Frohman, TC, Calabresi, PA, Cutter, G, Balcer, LJ. Optical coherence tomography: A window into the mechanisms of multiple sclerosis. Nat Clin Pract Neurol December 2008;4(12):664–75.
37.Saidha, S, Eckstein, C, Ratchford, JN. Optical coherence tomography as a marker of axonal damage in multiple sclerosis. CML – Multiple Sclerosis 2010;2(2):33–43.
38.Toussaint, D, Perier, O, Verstappen, A, Bervoets, S. Clinicopathological study of the visual pathways, eyes, and cerebral hemispheres in 32 cases of disseminated sclerosis. J Clin Neuroophthalmol September 1983;3(3):211–20.
39.Ikuta, F, Zimmerman, HM. Distribution of plaques in seventy autopsy cases of multiple sclerosis in the united states. Neurology June 1976; 26(6 PT 2): 26–8.
40.Green, AJ, McQuaid, S, Hauser, SL, Allen, , Lyness, R. Ocular pathology in multiple sclerosis: Retinal atrophy and inflammation irrespective of disease duration. Brain April 21, 2010;133(6):1591–601.
41.Kerrison, JB, Flynn, T, Green, WR. Retinal pathologic changes in multiple sclerosis. Retina 1994;14(5):445–51.
42.Naismith, RT, Xu, J, Tutlam, NT, Trinkaus, K, Cross, AH, Song, SK. Radial diffusivity in remote optic neuritis discriminates visual outcomes. Neurology May 25, 2010;74(21):1702–10.
43.Talman, LS, Bisker, ER, Sackel, DJ, Long, DA, Galetta, KM, Ratchford, JN, et al. Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis. Ann Neurol June 2010;67(6):749–60.
44.Papakostopoulos, D, Fotiou, F, Hart, JC, Banerji, NK. The electroretinogram in multiple sclerosis and demyelinating optic neuritis. Electroencephalogr Clin Neurophysiol January–February 1989;74(1):1–10.
45.Forooghian, F, Sproule, M, Westall, C, Gordon, L, Jirawuthiworavong, G, Shimazaki, K, et al. Electroretinographic abnormalities in multiple sclerosis: Possible role for retinal autoantibodies. Doc Ophthalmol September 2006;113(2):123–32.
46.Gundogan, FC, Demirkaya, S, Sobaci, G. Is optical coherence tomography really a new biomarker candidate in multiple sclerosis? – A structural and functional evaluation. Invest Ophthalmol Vis Sci December 2007;48(12):5773–81.
47.Gills, JP Electroretinographic abnormalities and advanced multiple sclerosis. Invest Ophthalmol December 1966;5(6):555–9.
48.Gelfand, JM, Nolan, R, Schwartz, DM, Graves, J, Green, AJ. Microcystic macular edema in multiple sclerosis is associated with disease severity. Brain June 2012;135(Pt 6):1786–93.
49.Saidha, S, Sotirchos, ES, Ibrahim, MA, Crainiceanu, CM, Gelfand, JM, Sepah, YJ, et al. Microcystic macular edema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: A retrospective study. Lancet Neurol November 2012;11(11):963–72.
50.Brar, M, Yuson, R, Kozak, I, Mojana, F, Cheng, L, Bartsch, DU, et al. Correlation between morphologic features on spectral-domain optical coherence tomography and angiographic leakage patterns in macular edema. Retina March 2010;30(3):383–9.
51.Sotirchos, ES, Saidha, S, Byraiah, G, Mealy, MA, Ibrahim, MA, Sepah, YJ, et al. In vivo identification of morphologic retinal abnormalities in neuromyelitis optica. Neurology April 9, 2013;80(15):1406–14.
52.Kaufhold, F, Zimmermann, H, Schneider, E, Ruprecht, K, Paul, F, Oberwahrenbrock, T, et al. Optic neuritis is associated with inner nuclear layer thickening and microcystic macular edema independently of multiple sclerosis. PLoS One August 6, 2013;8(8):e71145.
53.Barboni, P, Carelli, V, Savini, G, Carbonelli, M, La Morgia, C, Sadun, AA. Microcystic macular degeneration from optic neuropathy: Not inflammatory, not trans-synaptic degeneration. Brain July 2013;136(Pt 7):e239.
54.Wolff, B, Basdekidou, C, Vasseur, V, Mauget-Faysse, M, Sahel, JA, Vignal, C. Retinal inner nuclear layer microcystic changes in optic nerve atrophy: A novel spectral-domain OCT finding. Retina November–December 2013;33(10):2133–8.
55.Gills, JP, Wadsworth, JA. Degeneration of the inner nuclear layer of the retina following lesions of the optic nerve. Trans Am Ophthalmol Soc 1966;64:66–88.
56.Engell, T, Hvidberg, A, Uhrenholdt, A. Multiple sclerosis: Periphlebitis retinalis et cerebro-spinalis. A correlation between periphlebitis retinalis and abnormal technetium brain scintigraphy. Acta Neurol Scand May 1984;69(5):293–7.
57.Sepulcre, J, Murie-Fernandez, M, Salinas-Alaman, A, Garcia-Layana, A, Bejarano, B, Villoslada, P. Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS. Neurology May 2007;68(18):1488–94.
58.Ortiz-Perez, S, Martinez-Lapiscina, EH, Gabilondo, I, Fraga-Pumar, E, Martinez-Heras, E, Saiz, A, et al. Retinal periphlebitis is associated with multiple sclerosis severity. Neurology. September 3, 2013;81(10):877–81.
59.Donaldson, MJ, Pulido, JS, Herman, DC, Diehl, N, Hodge, D. Pars planitis: A 20-year study of incidence, clinical features, and outcomes. Am J Ophthalmol December 2007;144(6):812–7.
60.Gordon-Lipkin, E, Chodkowski, B, Reich, DS, Smith, SA, Pulicken, M, Balcer, LJ, et al. Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis. Neurology October 16, 2007;69(16):1603–9.
61.Grazioli, E, Zivadinov, R, Weinstock-Guttman, B, Lincoff, N, Baier, M, Wong, JR, et al. Retinal nerve fiber layer thickness is associated with brain MRI outcomes in multiple sclerosis. J Neurol Sci May 15, 2008;268(1–2):12–7.
62.Siger, M, Dziegielewski, K, Jasek, L, Bieniek, M, Nicpan, A, Nawrocki, J, et al. Optical coherence tomography in multiple sclerosis: Thickness of the retinal nerve fiber layer as a potential measure of axonal loss and brain atrophy. J Neurol October 2008;255(10):1555–60.
63.Dorr, J, Wernecke, KD, Bock, M, Gaede, G, Wuerfel, JT, Pfueller, CF, et al. Association of retinal and macular damage with brain atrophy in multiple sclerosis. PLoS One April 8, 2011;6(4):e18132.
64.Reich, DS, Smith, SA, Gordon-Lipkin, EM, Ozturk, A, Caffo, BS, Balcer, LJ, et al. Damage to the optic radiation in multiple sclerosis is associated with retinal injury and visual disability. Arch Neurol August 2009;66(8):998–1006.
65.Pfueller, CF, Brandt, AU, Schubert, F, Bock, M, Walaszek, B, Waiczies, H, et al. Metabolic changes in the visual cortex are linked to retinal nerve fiber layer thinning in multiple sclerosis. PLoS One April 6, 2011;6(4):e18019.
66.Syc, SB, Warner, CV, Hiremath, GS, Farrell, SK, Ratchford, JN, Conger, A, et al. Reproducibility of high-resolution optical coherence tomography in multiple sclerosis. Multiple Sclerosis. July 2010;16(7):829–39.
67.Warner, CV, Syc, SB, Stankiewicz, AM, Hiremath, G, Farrell, SK, Crainiceanu, CM, et al. The impact of utilizing different optical coherence tomography devices for clinical purposes and in multiple sclerosis trials. PLoS One 2011;6(8):e22947.
68.Young, KL, Brandt, AU, Petzold, A, Reitz, LY, Lintze, F, Paul, F, et al. Loss of retinal nerve fibre layer axons indicates white but not grey matter damage in early multiple sclerosis. Eur J Neurol. May 2013;20(5):803–11.
69.Zimmermann, H, Freing, A, Kaufhold, F, Gaede, G, Bohn, E, Bock, M, et al. Optic neuritis interferes with optical coherence tomography and magnetic resonance imaging correlations. Multiple Sclerosis April 2013;19(4):443–50.
70.Saidha, S, Sotirchos, ES, Oh, J, Syc, SB, Seigo, MA, Shiee, N, et al. Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis. JAMA Neurol January 2013;70(1):34–43.
71.Gabilondo, I, Martinez-Lapiscina, EH, Martinez-Heras, E, Fraga-Pumar, E, Llufriu, S, Ortiz, S, et al. Trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis. Ann Neurol October 2, 2013;
72.Shiee, N, Bazin, PL, Zackowski, KM, Farrell, SK, Harrison, DM, Newsome, SD, et al. Revisiting brain atrophy and its relationship to disability in multiple sclerosis. PLoS One 2012;7(5):e37049